首页 > 最新文献

Skin health and disease最新文献

英文 中文
Epidemiology, clinical characteristics, flares and mortality of generalized pustular psoriasis: a nationwide register study in Finland. 广泛性脓疱性银屑病的流行病学、临床特征、发作和死亡率:芬兰的一项全国性登记研究。
Q3 Medicine Pub Date : 2025-10-09 eCollection Date: 2025-12-01 DOI: 10.1093/skinhd/vzaf076
Mirkka Koivusalo, Xavier Teitsma, Juha Mehtälä, Aino Vesikansa, Susanne Clemen Capion, Laura Airaksinen, Maria Grönman, Rafael Pasternack, Pauliina Nuutinen, Laura Huilaja

Background: Generalized pustular psoriasis (GPP) is a chronic and potentially life-threatening inflammatory disease characterized by recurrent, sudden flares often accompanied by systemic symptoms. With the introduction of new, targeted therapies for GPP there is an increased need to better understand patient characteristics to improve disease management.

Objectives: To assess the epidemiology of GPP, and compare clinical characteristics, treatments and overall survival between GPP and population-based controls and control participants with psoriasis vulgaris. Furthermore, flare occurrence and risk factors for flares were also assessed.

Methods: All Finnish patients with ≥1 GPP diagnosis (International Classification of Diseases, Tenth Revision: L40.1) in secondary healthcare between 1996 and 2021 and age- and sex-matched control groups were identified. Data on diagnoses, medications and deaths were collected from national registers. Incidence and prevalence were assessed using different case criteria. The primary analysis group included patients with ≥2 GPP diagnoses at a dermatology clinic in specialty care.

Results: GPP period prevalence decreased from 9.9 to 4.7 and the incidence rate from 4.2 to 2.1 per 100 000 when using stricter case criteria. Psoriasis (73%) and hypertension (49%) were the most common comorbidities among patients with GPP, and topical corticosteroids were the most used medication (92%; P < 0.05 vs. control groups). Overall survival was lower in GPP compared with both control groups (P < 0.001). In total, 43% of the patients experienced a flare during follow-up, of which one-third (33%) had a flare at the time of first GPP diagnosis. Systemic corticosteroid use [hazard ratio (HR) 1.41; 95% confidence interval (CI) 1.10-1.81; P = 0.007] was associated with a higher risk of GPP flares and flares were associated with an increased risk of death (HR 1.7; 95% CI 1.08-2.60; P < 0.05).

Conclusions: The epidemiology of GPP in Finland was found to be comparable to previously published estimates and associated with a high disease burden and shorter overall survival. Flares occurred frequently during follow-up and are associated with an increased risk of death. Standardized guidelines are crucial to improve the timely diagnosis and management of the disease.

背景:全身性脓疱性牛皮癣(GPP)是一种慢性和潜在威胁生命的炎症性疾病,其特征是反复发作,突然发作,常伴有全身症状。随着新的靶向治疗GPP的引入,更好地了解患者特征以改善疾病管理的需求增加。目的:评估GPP的流行病学,比较GPP与基于人群的对照组和普通银屑病对照组的临床特征、治疗方法和总生存率。此外,还对耀斑的发生和危险因素进行了评估。方法:选取1996年至2021年间在二级医疗机构中GPP诊断≥1(国际疾病分类,第十版:L40.1)的所有芬兰患者以及年龄和性别匹配的对照组。有关诊断、药物和死亡的数据是从国家登记册中收集的。发病率和流行率采用不同的病例标准进行评估。主要分析组包括在皮肤科诊所接受专科护理诊断的GPP≥2例的患者。结果:采用更严格的病例标准时,GPP期患病率从9.9降至4.7,发病率从4.2降至2.1 / 10万。银屑病(73%)和高血压(49%)是GPP患者最常见的合并症,外用皮质类固醇是使用最多的药物(92%,与对照组相比P < 0.05)。与对照组相比,GPP组的总生存率较低(P < 0.001)。总体而言,43%的患者在随访期间出现了耀斑,其中三分之一(33%)在首次GPP诊断时出现了耀斑。全身使用皮质类固醇[危险比(HR) 1.41;95%置信区间(CI) 1.10-1.81;P = 0.007]与GPP耀斑的高风险相关,而耀斑与死亡风险增加相关(HR 1.7; 95% CI 1.08-2.60; P < 0.05)。结论:芬兰GPP的流行病学发现与先前公布的估计相当,并与高疾病负担和较短的总生存期相关。在随访期间经常发生耀斑,并与死亡风险增加有关。标准化的指南对于提高疾病的及时诊断和管理至关重要。
{"title":"Epidemiology, clinical characteristics, flares and mortality of generalized pustular psoriasis: a nationwide register study in Finland.","authors":"Mirkka Koivusalo, Xavier Teitsma, Juha Mehtälä, Aino Vesikansa, Susanne Clemen Capion, Laura Airaksinen, Maria Grönman, Rafael Pasternack, Pauliina Nuutinen, Laura Huilaja","doi":"10.1093/skinhd/vzaf076","DOIUrl":"https://doi.org/10.1093/skinhd/vzaf076","url":null,"abstract":"<p><strong>Background: </strong>Generalized pustular psoriasis (GPP) is a chronic and potentially life-threatening inflammatory disease characterized by recurrent, sudden flares often accompanied by systemic symptoms. With the introduction of new, targeted therapies for GPP there is an increased need to better understand patient characteristics to improve disease management.</p><p><strong>Objectives: </strong>To assess the epidemiology of GPP, and compare clinical characteristics, treatments and overall survival between GPP and population-based controls and control participants with psoriasis vulgaris. Furthermore, flare occurrence and risk factors for flares were also assessed.</p><p><strong>Methods: </strong>All Finnish patients with ≥1 GPP diagnosis (International Classification of Diseases, Tenth Revision: L40.1) in secondary healthcare between 1996 and 2021 and age- and sex-matched control groups were identified. Data on diagnoses, medications and deaths were collected from national registers. Incidence and prevalence were assessed using different case criteria. The primary analysis group included patients with ≥2 GPP diagnoses at a dermatology clinic in specialty care.</p><p><strong>Results: </strong>GPP period prevalence decreased from 9.9 to 4.7 and the incidence rate from 4.2 to 2.1 per 100 000 when using stricter case criteria. Psoriasis (73%) and hypertension (49%) were the most common comorbidities among patients with GPP, and topical corticosteroids were the most used medication (92%; <i>P</i> < 0.05 vs. control groups). Overall survival was lower in GPP compared with both control groups (<i>P</i> < 0.001). In total, 43% of the patients experienced a flare during follow-up, of which one-third (33%) had a flare at the time of first GPP diagnosis. Systemic corticosteroid use [hazard ratio (HR) 1.41; 95% confidence interval (CI) 1.10-1.81; <i>P</i> = 0.007] was associated with a higher risk of GPP flares and flares were associated with an increased risk of death (HR 1.7; 95% CI 1.08-2.60; <i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>The epidemiology of GPP in Finland was found to be comparable to previously published estimates and associated with a high disease burden and shorter overall survival. Flares occurred frequently during follow-up and are associated with an increased risk of death. Standardized guidelines are crucial to improve the timely diagnosis and management of the disease.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 6","pages":"432-442"},"PeriodicalIF":0.0,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12648532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of chronic actinic dermatitis in a patient with atopic dermatitis: a case report and a review of reported cases. 特应性皮炎患者慢性光化性皮炎的发展:一个病例报告和报告病例的回顾。
Q3 Medicine Pub Date : 2025-10-09 eCollection Date: 2025-12-01 DOI: 10.1093/skinhd/vzaf068
Anri Kimura, Teruhiko Makino, Keita Takemoto, Shohei Kitayama, Megumi Mizawa, Tadamichi Shimizu

A 30-year-old Japanese woman who had suffered from atopic dermatitis (AD) since childhood was referred for the evaluation of itchy erythema in sun-exposed regions, which persisted for 3 years. Phototesting revealed that the minimal erythema dose (MED) to ultraviolet (UV)B radiation was 20 mJ cm-2 and MED to UVA radiation was 10 J cm-2. Phototesting with visible light revealed no positive reaction. The skin lesion was diagnosed as chronic actinic dermatitis (CAD). She was asked to strictly avoid exposure to sunlight; thereafter, her skin symptoms disappeared. There have been 18 reported cases of CAD developing in patients with AD, including our patient. Interestingly, CAD appeared before the age of 30 years in 15 of the 18 cases, suggesting that the age of onset of CAD in patients with AD may be younger than that in typical patients with CAD. Accordingly, we recommend performing phototesting on patients with AD with features of photoaggravated dermatitis to diagnose photosensitivity and provide appropriate management.

一名30岁的日本女性,从小患有特应性皮炎(AD),被转介评估暴露在阳光下的瘙痒性红斑,持续3年。光检测结果显示,紫外光(UV)B照射下的最小红斑剂量(MED)为20 mJ cm-2, UVA照射下的最小红斑剂量(MED)为10 J cm-2。可见光光试验未见阳性反应。诊断为慢性光化性皮炎(CAD)。她被要求严格避免暴露在阳光下;此后,她的皮肤症状消失了。包括本例患者在内,已有18例AD患者发生CAD的报道。有趣的是,18例中有15例CAD出现在30岁之前,这表明AD患者的CAD发病年龄可能比典型CAD患者的发病年龄要小。因此,我们建议对具有光加重性皮炎特征的AD患者进行光检测,以诊断光敏性并提供适当的治疗。
{"title":"Development of chronic actinic dermatitis in a patient with atopic dermatitis: a case report and a review of reported cases.","authors":"Anri Kimura, Teruhiko Makino, Keita Takemoto, Shohei Kitayama, Megumi Mizawa, Tadamichi Shimizu","doi":"10.1093/skinhd/vzaf068","DOIUrl":"https://doi.org/10.1093/skinhd/vzaf068","url":null,"abstract":"<p><p>A 30-year-old Japanese woman who had suffered from atopic dermatitis (AD) since childhood was referred for the evaluation of itchy erythema in sun-exposed regions, which persisted for 3 years. Phototesting revealed that the minimal erythema dose (MED) to ultraviolet (UV)B radiation was 20 mJ cm<sup>-2</sup> and MED to UVA radiation was 10 J cm<sup>-2</sup>. Phototesting with visible light revealed no positive reaction. The skin lesion was diagnosed as chronic actinic dermatitis (CAD). She was asked to strictly avoid exposure to sunlight; thereafter, her skin symptoms disappeared. There have been 18 reported cases of CAD developing in patients with AD, including our patient. Interestingly, CAD appeared before the age of 30 years in 15 of the 18 cases, suggesting that the age of onset of CAD in patients with AD may be younger than that in typical patients with CAD. Accordingly, we recommend performing phototesting on patients with AD with features of photoaggravated dermatitis to diagnose photosensitivity and provide appropriate management.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 6","pages":"463-466"},"PeriodicalIF":0.0,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12648553/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lichen sclerosus in paediatric patients with phimosis undergoing circumcision. 包皮环切术中包茎患者的硬化性地衣。
Q3 Medicine Pub Date : 2025-10-07 eCollection Date: 2025-12-01 DOI: 10.1093/skinhd/vzaf065
Nada Aboukhatwah, Sandra Jerkovic Gulin, Christopher B Bunker, Michalis Varnavas, Georgios Kravvas

Background: Male genital lichen sclerosus is a relatively uncommon but increasingly recognized cause of phimosis in paediatric patients.

Objectives: To investigate the presence of male genital lichen sclerosus (MGLS) in paediatric patients presenting with phimosis and to evaluate the diagnostic accuracy of clinical assessment compared with histopathological findings.

Methods: We conducted a single-centre, retrospective study of 48 paediatric circumcisions performed for phimosis over an 18-month period. Clinical diagnoses of phimosis were categorized as physiological or pathological and compared with postoperative histopathological findings. To quantify diagnostic reliability, percentage agreement and Cohen's kappa coefficient were used.

Results: MGLS was confirmed histologically in 71% of patients, with the highest proportion occurring in boys aged 9-11 years. Among those clinically diagnosed with physiological phimosis, 70% showed histological evidence of MGLS, of whom 48% exhibited extensive disease. The overall concordance between clinical and histological diagnoses was 43.75%, with a Kappa value of 0.027, indicating only slight agreement.

Conclusions: Currently, clinical assessments seem to underestimate the proportion of cases with MGLS, especially among younger boys. Enhancing awareness and recognition of this condition is essential to facilitate accurate and timely diagnosis, and to guide appropriate interventions, thereby preventing disease progression and reducing associated morbidity.

背景:男性生殖器硬化地衣是一种相对罕见但越来越多的认识到的原因包茎在儿科患者。目的:探讨以包茎为临床表现的儿童男性生殖器硬化地衣(MGLS)的存在,并比较临床评估与组织病理学结果的诊断准确性。方法:我们进行了一项单中心回顾性研究,在18个月的时间里对48例包皮环切术进行了包茎手术。将包茎的临床诊断分为生理性和病理性,并与术后组织病理学结果进行比较。为了量化诊断可靠性,使用了百分比一致性和Cohen’s kappa系数。结果:71%的患者经组织学证实为MGLS,以9-11岁男孩的比例最高。在临床诊断为生理性包茎的患者中,70%表现为MGLS的组织学证据,其中48%表现为广泛病变。临床诊断与组织学诊断的总体一致性为43.75%,Kappa值为0.027,一致性较低。结论:目前,临床评估似乎低估了MGLS病例的比例,特别是在年轻男孩中。提高对这种情况的认识和认识对于促进准确和及时的诊断并指导适当的干预措施,从而预防疾病进展和减少相关发病率至关重要。
{"title":"Lichen sclerosus in paediatric patients with phimosis undergoing circumcision.","authors":"Nada Aboukhatwah, Sandra Jerkovic Gulin, Christopher B Bunker, Michalis Varnavas, Georgios Kravvas","doi":"10.1093/skinhd/vzaf065","DOIUrl":"https://doi.org/10.1093/skinhd/vzaf065","url":null,"abstract":"<p><strong>Background: </strong>Male genital lichen sclerosus is a relatively uncommon but increasingly recognized cause of phimosis in paediatric patients.</p><p><strong>Objectives: </strong>To investigate the presence of male genital lichen sclerosus (MGLS) in paediatric patients presenting with phimosis and to evaluate the diagnostic accuracy of clinical assessment compared with histopathological findings.</p><p><strong>Methods: </strong>We conducted a single-centre, retrospective study of 48 paediatric circumcisions performed for phimosis over an 18-month period. Clinical diagnoses of phimosis were categorized as physiological or pathological and compared with postoperative histopathological findings. To quantify diagnostic reliability, percentage agreement and Cohen's kappa coefficient were used.</p><p><strong>Results: </strong>MGLS was confirmed histologically in 71% of patients, with the highest proportion occurring in boys aged 9-11 years. Among those clinically diagnosed with physiological phimosis, 70% showed histological evidence of MGLS, of whom 48% exhibited extensive disease. The overall concordance between clinical and histological diagnoses was 43.75%, with a Kappa value of 0.027, indicating only slight agreement.</p><p><strong>Conclusions: </strong>Currently, clinical assessments seem to underestimate the proportion of cases with MGLS, especially among younger boys. Enhancing awareness and recognition of this condition is essential to facilitate accurate and timely diagnosis, and to guide appropriate interventions, thereby preventing disease progression and reducing associated morbidity.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 6","pages":"426-431"},"PeriodicalIF":0.0,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12648523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Baricitinib improved morphoea manifestations in a patient with alopecia areata universalis. Baricitinib改善普遍斑秃患者的形态表现。
Q3 Medicine Pub Date : 2025-10-01 eCollection Date: 2025-12-01 DOI: 10.1093/skinhd/vzaf071
Vincenzina Rubino, Maria E Baffa, Carlo Pipitò, Samuele Savian, Stefano Senatore, Roberto Maglie, Emiliano Antiga

In our clinical case, the patient, affected by morphea, reported an excellent response to the administration of baricitinib 4 mg day-1, with rapid disappearance of itching and reduction of the erythematous-infiltrative component of the plaques, highlighting the important role of the JAK/STAT pathway in TGF-β-mediated profibrotic signalling.

在我们的临床病例中,受morphea影响的患者报告对baricitinib 4mg day-1给予极好的反应,瘙痒迅速消失,斑块红斑浸润成分减少,突出了JAK/STAT通路在TGF-β介导的纤维化信号传导中的重要作用。
{"title":"Baricitinib improved morphoea manifestations in a patient with alopecia areata universalis.","authors":"Vincenzina Rubino, Maria E Baffa, Carlo Pipitò, Samuele Savian, Stefano Senatore, Roberto Maglie, Emiliano Antiga","doi":"10.1093/skinhd/vzaf071","DOIUrl":"https://doi.org/10.1093/skinhd/vzaf071","url":null,"abstract":"<p><p>In our clinical case, the patient, affected by morphea, reported an excellent response to the administration of baricitinib 4 mg day<sup>-1</sup>, with rapid disappearance of itching and reduction of the erythematous-infiltrative component of the plaques, highlighting the important role of the JAK/STAT pathway in TGF-β-mediated profibrotic signalling.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 6","pages":"495-496"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12648563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany. 在特应性皮炎的常规护理中接受杜匹单抗治疗的患者的2年随访中,大湿疹面积和严重程度指数反应:来自德国国家登记中心的结果。
Q3 Medicine Pub Date : 2025-10-01 eCollection Date: 2025-12-01 DOI: 10.1093/skinhd/vzaf075
Luise Heinrich, Thomas Birkner, Susanne Abraham, Sascha Gerdes, Tatjana Honstein, Sigrid Müller, Matthias Augustin, Inken Harder, Thomas Schaefer, Andreas Pinter, Anne Bong, Jutta Ramaker-Brunke, Tilo Biedermann, Michael Sticherling, Hannah Gorriahn-Maiterth, Knut Schäkel, Beate Schwarz, Sven Quist, Mohammad Asefi, Nicole Adler, Maren Stahl, Michael Schulz-Kiesow, Florian Schenck, Thomas Werfel, Stephan Weidinger, Annice Heratizadeh, Jochen Schmitt

The TREATgermany registry was set up in 2016. We provide results on long-term dupilumab therapy in adults with moderate and severe atopic dermatitis (AD) in a routine care setting. The analysis cohort of 294 patients is one of the largest cohorts with 2-year follow-up data on treatment effects of dupilumab obtained from an AD registry to date. We report the Harmonising Outcome Measures for Eczema (HOME) core outcome set. The Eczema Area Severity Index (EASI) 75 and EASI 90 response rates for patients on treatment at month 24 were 78.8% and 51.2%, respectively.

德国治疗中心于2016年成立。我们在常规护理环境中提供成人中度和重度特应性皮炎(AD)长期dupilumab治疗的结果。294例患者的分析队列是迄今为止从AD注册中心获得的dupilumab治疗效果2年随访数据的最大队列之一。我们报告了湿疹的协调结果测量(HOME)核心结果集。患者在第24个月接受治疗时,湿疹面积严重指数(EASI) 75和EASI 90的有效率分别为78.8%和51.2%。
{"title":"Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany.","authors":"Luise Heinrich, Thomas Birkner, Susanne Abraham, Sascha Gerdes, Tatjana Honstein, Sigrid Müller, Matthias Augustin, Inken Harder, Thomas Schaefer, Andreas Pinter, Anne Bong, Jutta Ramaker-Brunke, Tilo Biedermann, Michael Sticherling, Hannah Gorriahn-Maiterth, Knut Schäkel, Beate Schwarz, Sven Quist, Mohammad Asefi, Nicole Adler, Maren Stahl, Michael Schulz-Kiesow, Florian Schenck, Thomas Werfel, Stephan Weidinger, Annice Heratizadeh, Jochen Schmitt","doi":"10.1093/skinhd/vzaf075","DOIUrl":"https://doi.org/10.1093/skinhd/vzaf075","url":null,"abstract":"<p><p>The TREATgermany registry was set up in 2016. We provide results on long-term dupilumab therapy in adults with moderate and severe atopic dermatitis (AD) in a routine care setting. The analysis cohort of 294 patients is one of the largest cohorts with 2-year follow-up data on treatment effects of dupilumab obtained from an AD registry to date. We report the Harmonising Outcome Measures for Eczema (HOME) core outcome set. The Eczema Area Severity Index (EASI) 75 and EASI 90 response rates for patients on treatment at month 24 were 78.8% and 51.2%, respectively.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 6","pages":"490-492"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12648515/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent melanoma presenting as a rash: a case report. 复发性黑色素瘤表现为皮疹:一例报告。
Q3 Medicine Pub Date : 2025-10-01 eCollection Date: 2025-12-01 DOI: 10.1093/skinhd/vzaf073
Annabelle Huntsman, Katherine Gillis, Anneli R Bowen, Dekker C Deacon

Melanoma is the most aggressive form of common skin cancer and recurrence, while rare, typically presents as pigmented papules or nodules near the primary site. Here, we describe a case of a woman with stage IIIC melanoma undergoing intralesional talimogene laherparepvec (T-VEC) therapy who developed a spreading erythematous rash on her left leg, accompanied by fatigue and leg swelling. Skin biopsy revealed recurrent melanoma, with SOX10 and Melan-A positivity, and imaging showed features concerning for multifocal disease recurrence in the left popliteal fossa. This case highlights an unusual presentation of melanoma recurrence and underscores the importance of biopsy in -evaluating new skin findings in patients with a history of melanoma.

黑色素瘤是最具侵袭性的常见皮肤癌和复发,虽然罕见,通常表现为原发部位附近的色素丘疹或结节。在这里,我们描述了一例患有IIIC期黑色素瘤的女性患者,她正在接受病灶内talimogene laherparepvec (T-VEC)治疗,她的左腿出现了弥漫性红斑疹,并伴有疲劳和腿部肿胀。皮肤活检显示复发性黑色素瘤,SOX10和Melan-A阳性,影像学显示左腘窝多灶性疾病复发的特征。本病例强调了黑色素瘤复发的不寻常表现,并强调了活检在评估黑色素瘤病史患者新皮肤发现中的重要性。
{"title":"Recurrent melanoma presenting as a rash: a case report.","authors":"Annabelle Huntsman, Katherine Gillis, Anneli R Bowen, Dekker C Deacon","doi":"10.1093/skinhd/vzaf073","DOIUrl":"https://doi.org/10.1093/skinhd/vzaf073","url":null,"abstract":"<p><p>Melanoma is the most aggressive form of common skin cancer and recurrence, while rare, typically presents as pigmented papules or nodules near the primary site. Here, we describe a case of a woman with stage IIIC melanoma undergoing intralesional talimogene laherparepvec (T-VEC) therapy who developed a spreading erythematous rash on her left leg, accompanied by fatigue and leg swelling. Skin biopsy revealed recurrent melanoma, with SOX10 and Melan-A positivity, and imaging showed features concerning for multifocal disease recurrence in the left popliteal fossa. This case highlights an unusual presentation of melanoma recurrence and underscores the importance of biopsy in -evaluating new skin findings in patients with a history of melanoma.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 6","pages":"474-477"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12648550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical waves: nonsporotrichoid Mycobacterium marinum skin infection in an immunocompromised scuba diver. 非典型波浪:免疫功能低下潜水员的非孢子毛状海洋分枝杆菌皮肤感染。
Q3 Medicine Pub Date : 2025-10-01 eCollection Date: 2025-12-01 DOI: 10.1093/skinhd/vzaf072
Claudine Howard-James, Caoimhe Brennan, Anna-Rose Prior, Stephen Crowther, Jack Allen, Anne-Marie McLaughlin, Joseph Keane, Kevin Molloy

A 58-year-old man presented with an enlarging painful ulcer on his left medial knee. He had a history of psoriatic arthritis, treated with methotrexate and adalimumab for the last 5 years. He had travelled to over 20 countries in the past 2 years, and his hobbies included scuba diving and seawater/freshwater swimming. He recalled freshwater swimming in a cave lake in Brazil 1 year prior. Subsequently, he developed small erythematous papules on each knee with rapid resolution on the right knee. The left knee lesion slowly enlarged, and he sought medical attention in Ireland 9 months later. He received antibiotics and topical steroids, and was switched from adalimumab to infliximab for a presumed diagnosis of pyoderma gangrenosum. The lesion's growth accelerated over 8 weeks, leading to an acute presentation to the Emergency Department with severe pain and limited mobility. On examination, he had a 20 × 10 cm erosive plaque on his left knee with an exudative base and a ragged erythematous edge. He also had a 2.5 × 2 cm ulcerative lesion on his right flank and a hyperpigmented patch on his right knee. He denied fevers or systemic symptoms. Interferon-γ release assay was positive. A skin biopsy from the left leg demonstrated ulceration, mixed inflammation and underlying dermal necrosis. Necrotizing granulomas were seen, and both auramine and Ziehl-Neelsen stains were positive for abundant acid-fast bacilli. Skin biopsy from the right flank showed similar findings. A mycobacterial culture was incubated at 30°C and after 4 weeks, Mycobacterium marinum was identified. Mycobacterium marinum is a free-living, slow-growing, nontuberculous mycobacterium found in cold and warm fresh and saltwater environments. It can cause a tuberculosis-like disease in fish and can opportunistically infect humans when injured skin is exposed to a contaminated aqueous environment. The typical presentation is a 'fish tank granuloma': nodules, plaques or ulcerated lesions that spread in a sporotrichoid pattern along lines of lymphatics, commonly on the upper limb. This case represents a highly unusual cutaneous M. marinum presentation, with noncontiguous ulcerative lesions in an immunocompromised host. The diagnostic delay highlights the challenges of recognizing atypical nontuberculous mycobacterial infections, particularly in patients who are immunosuppressed.

一个58岁的男人提出了一个扩大疼痛溃疡在他的左膝内侧。他有银屑病关节炎病史,过去5年接受甲氨蝶呤和阿达木单抗治疗。在过去的两年里,他去过20多个国家,他的爱好包括水肺潜水和海水/淡水游泳。他回忆起一年前在巴西的一个洞穴湖里游泳。随后,患者双膝出现小红斑丘疹,右膝迅速消退。左膝病变逐渐扩大,9个月后他到爱尔兰求医。他接受了抗生素和局部类固醇治疗,并因推定诊断为坏疽性脓皮病而从阿达木单抗转为英夫利昔单抗。病变的生长加速超过8周,导致急诊科出现严重疼痛和活动受限的急性症状。检查时,患者左膝有一块20 × 10厘米的糜烂斑块,底部渗出,边缘呈不规则红斑。他的右侧也有一个2.5 × 2厘米的溃疡性病变,右膝有一个色素沉着的斑块。他否认发烧或全身症状。干扰素γ释放试验阳性。左腿的皮肤活检显示溃疡,混合炎症和潜在的皮肤坏死。可见坏死性肉芽肿,auramine和Ziehl-Neelsen染色显示大量抗酸杆菌。右侧皮肤活检显示类似结果。在30°C下培养分枝杆菌,4周后鉴定出海洋分枝杆菌。海洋分枝杆菌是一种自由生活、生长缓慢的非结核分枝杆菌,存在于寒冷和温暖的淡水和咸水环境中。它可在鱼类中引起结核样疾病,并可在受伤的皮肤暴露于受污染的水环境时机会性地感染人类。典型的表现是“鱼缸肉芽肿”:结节、斑块或溃疡性病变,沿淋巴管呈孢子状扩散,常见于上肢。这个病例是一个非常不寻常的皮肤海洋分枝杆菌的表现,在免疫功能低下的宿主中有不连续的溃疡性病变。诊断延迟突出了识别非典型非结核分枝杆菌感染的挑战,特别是在免疫抑制的患者中。
{"title":"Atypical waves: nonsporotrichoid <i>Mycobacterium marinum</i> skin infection in an immunocompromised scuba diver.","authors":"Claudine Howard-James, Caoimhe Brennan, Anna-Rose Prior, Stephen Crowther, Jack Allen, Anne-Marie McLaughlin, Joseph Keane, Kevin Molloy","doi":"10.1093/skinhd/vzaf072","DOIUrl":"https://doi.org/10.1093/skinhd/vzaf072","url":null,"abstract":"<p><p>A 58-year-old man presented with an enlarging painful ulcer on his left medial knee. He had a history of psoriatic arthritis, treated with methotrexate and adalimumab for the last 5 years. He had travelled to over 20 countries in the past 2 years, and his hobbies included scuba diving and seawater/freshwater swimming. He recalled freshwater swimming in a cave lake in Brazil 1 year prior. Subsequently, he developed small erythematous papules on each knee with rapid resolution on the right knee. The left knee lesion slowly enlarged, and he sought medical attention in Ireland 9 months later. He received antibiotics and topical steroids, and was switched from adalimumab to infliximab for a presumed diagnosis of pyoderma gangrenosum. The lesion's growth accelerated over 8 weeks, leading to an acute presentation to the Emergency Department with severe pain and limited mobility. On examination, he had a 20 × 10 cm erosive plaque on his left knee with an exudative base and a ragged erythematous edge. He also had a 2.5 × 2 cm ulcerative lesion on his right flank and a hyperpigmented patch on his right knee. He denied fevers or systemic symptoms. Interferon-γ release assay was positive. A skin biopsy from the left leg demonstrated ulceration, mixed inflammation and underlying dermal necrosis. Necrotizing granulomas were seen, and both auramine and Ziehl-Neelsen stains were positive for abundant acid-fast bacilli. Skin biopsy from the right flank showed similar findings. A mycobacterial culture was incubated at 30°C and after 4 weeks, <i>Mycobacterium marinum</i> was identified. <i>Mycobacterium marinum</i> is a free-living, slow-growing, nontuberculous mycobacterium found in cold and warm fresh and saltwater environments. It can cause a tuberculosis-like disease in fish and can opportunistically infect humans when injured skin is exposed to a contaminated aqueous environment. The typical presentation is a 'fish tank granuloma': nodules, plaques or ulcerated lesions that spread in a sporotrichoid pattern along lines of lymphatics, commonly on the upper limb. This case represents a highly unusual cutaneous <i>M. marinum</i> presentation, with noncontiguous ulcerative lesions in an immunocompromised host. The diagnostic delay highlights the challenges of recognizing atypical nontuberculous mycobacterial infections, particularly in patients who are immunosuppressed.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 6","pages":"470-473"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12648512/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sebum's effect on wound healing and pigmentation in mice. 皮脂对小鼠伤口愈合和色素沉着的影响。
Q3 Medicine Pub Date : 2025-09-17 eCollection Date: 2025-10-01 DOI: 10.1093/skinhd/vzaf037
Kyung-Ju Lee, Hye-Young An, Gwang Seong Choi, Hyun-Tae Shin, Jeonghyun Shin

Background: Wound healing is often followed by postinflammatory hyperpigmentation (PIH), which commonly develops in sebum-poor areas.

Objectives: To investigate the effects of sebum on wound healing, especially relative to basement membrane recovery and PIH.

Methods: Using 100% trichloroacetic acid, we created deep dermal wounds on both sides of male HRM-2 hairless melanin-containing mice. The left side served as the control group, while the right side received daily sebum application for 21 days. The wound healing status and degree of pigmentation were evaluated by visual wound assessments and image analyses. Histological analysis and electron microscopy (EM) examinations were performed on days 7, 14 and 21, to compare basement membrane recovery and pigmentation.

Results: The sebum group exhibited faster wound healing, including quicker crust removal and wound contraction, and reduced pigmentation, although this difference was not statistically significant. Histological and EM analyses seemed to show accelerated basement membrane recovery and delayed onset of melanosome accumulation with sebum treatment. We also performed cell viability and melanin contents assays using B16F10 melanoma cells, revealing that sebum decreased melanogenesis by inhibiting tyrosinase activity, without cytotoxicity.

Conclusions: Overall, our results suggest that sebum might promote wound healing, with faster basement membrane recovery, and reduce PIH.

背景:伤口愈合后通常会出现炎症后色素沉着(PIH),通常发生在皮脂缺乏的区域。目的:探讨皮脂对创面愈合的影响,特别是对基底膜恢复和PIH的影响。方法:用100%三氯乙酸对雄性HRM-2无毛黑色素小鼠双侧皮肤深层创面。左侧为对照组,右侧每日涂抹皮脂21 d。采用视觉创面评价和图像分析评价创面愈合情况和色素沉着程度。在第7、14和21天进行组织学分析和电镜检查,比较基底膜恢复和色素沉着。结果:皮脂组伤口愈合更快,包括更快的痂皮去除和伤口收缩,色素沉着减少,尽管这种差异没有统计学意义。组织学和电镜分析似乎显示,皮脂治疗加速了基底膜的恢复,延迟了黑素体积累的发生。我们还使用B16F10黑色素瘤细胞进行了细胞活力和黑色素含量测定,发现皮脂通过抑制酪氨酸酶活性来减少黑色素生成,而没有细胞毒性。结论:总体而言,我们的研究结果表明皮脂可能促进伤口愈合,加快基底膜恢复,并减少PIH。
{"title":"Sebum's effect on wound healing and pigmentation in mice.","authors":"Kyung-Ju Lee, Hye-Young An, Gwang Seong Choi, Hyun-Tae Shin, Jeonghyun Shin","doi":"10.1093/skinhd/vzaf037","DOIUrl":"10.1093/skinhd/vzaf037","url":null,"abstract":"<p><strong>Background: </strong>Wound healing is often followed by postinflammatory hyperpigmentation (PIH), which commonly develops in sebum-poor areas.</p><p><strong>Objectives: </strong>To investigate the effects of sebum on wound healing, especially relative to basement membrane recovery and PIH.</p><p><strong>Methods: </strong>Using 100% trichloroacetic acid, we created deep dermal wounds on both sides of male HRM-2 hairless melanin-containing mice. The left side served as the control group, while the right side received daily sebum application for 21 days. The wound healing status and degree of pigmentation were evaluated by visual wound assessments and image analyses. Histological analysis and electron microscopy (EM) examinations were performed on days 7, 14 and 21, to compare basement membrane recovery and pigmentation.</p><p><strong>Results: </strong>The sebum group exhibited faster wound healing, including quicker crust removal and wound contraction, and reduced pigmentation, although this difference was not statistically significant. Histological and EM analyses seemed to show accelerated basement membrane recovery and delayed onset of melanosome accumulation with sebum treatment. We also performed cell viability and melanin contents assays using B16F10 melanoma cells, revealing that sebum decreased melanogenesis by inhibiting tyrosinase activity, without cytotoxicity.</p><p><strong>Conclusions: </strong>Overall, our results suggest that sebum might promote wound healing, with faster basement membrane recovery, and reduce PIH.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 5","pages":"344-356"},"PeriodicalIF":0.0,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12480736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coexisting elastosis perforans serpiginosa and acquired cutis laxa following long-term penicillamine in Wilson disease. Wilson病患者长期使用青霉胺后并发穿孔性蛇皮弹性病和获得性皮肤松弛症。
Q3 Medicine Pub Date : 2025-09-05 eCollection Date: 2025-12-01 DOI: 10.1093/skinhd/vzaf060
Tu-An Ma, Nicholas Van Rooij

We report a rare case of coexisting elastosis perforans serpiginosa and acquired cutis laxa in a patient with Wilson's disease following prolonged penicillamine therapy. This represents two rare but important dermatologic complications of long-term chelation therapy that clinicians should be aware of, given the potential for underlying elastin disruption to also affect systemic tissues.

我们报告一个罕见的病例,同时存在穿孔性丝虫病弹性弹性和获得性皮肤松弛症的威尔森氏病患者后,长期青霉胺治疗。这代表了长期螯合治疗的两种罕见但重要的皮肤病并发症,临床医生应该意识到,潜在的弹性蛋白破坏也可能影响全身组织。
{"title":"Coexisting elastosis perforans serpiginosa and acquired cutis laxa following long-term penicillamine in Wilson disease.","authors":"Tu-An Ma, Nicholas Van Rooij","doi":"10.1093/skinhd/vzaf060","DOIUrl":"https://doi.org/10.1093/skinhd/vzaf060","url":null,"abstract":"<p><p>We report a rare case of coexisting elastosis perforans serpiginosa and acquired cutis laxa in a patient with Wilson's disease following prolonged penicillamine therapy. This represents two rare but important dermatologic complications of long-term chelation therapy that clinicians should be aware of, given the potential for underlying elastin disruption to also affect systemic tissues.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 6","pages":"460-462"},"PeriodicalIF":0.0,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12648526/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to pembrolizumab in a patient with xeroderma pigmentosum, metastatic cutaneous melanoma and multiple squamous cell carcinomas: a case report. 派姆单抗对色素性干皮病、转移性皮肤黑色素瘤和多发性鳞状细胞癌患者的疗效:1例报告。
Q3 Medicine Pub Date : 2025-09-02 eCollection Date: 2025-10-01 DOI: 10.1093/skinhd/vzaf038
Júlia C Martins, Abna F S Vieira, Olavo Feher

Xeroderma pigmentosum (XP) is a rare genetic disorder associated with defective DNA repair, leading to extreme ultraviolet sensitivity and a significantly elevated risk of malignancies. This case report details a patient with XP and metastatic melanoma who achieved complete clinical remission with pembrolizumab, highlighting the potential efficacy of immune checkpoint inhibitors in tumours with high mutational burdens. These findings underscore a promising therapeutic avenue for this vulnerable population with limited treatment options.

着色性干皮病(XP)是一种罕见的遗传疾病,与DNA修复缺陷有关,导致极端紫外线敏感性和恶性肿瘤的风险显著升高。本病例报告详细介绍了一名XP和转移性黑色素瘤患者使用派姆单抗获得完全临床缓解,强调了免疫检查点抑制剂在高突变负担肿瘤中的潜在疗效。这些发现强调了这一治疗选择有限的弱势群体的有希望的治疗途径。
{"title":"Response to pembrolizumab in a patient with xeroderma pigmentosum, metastatic cutaneous melanoma and multiple squamous cell carcinomas: a case report.","authors":"Júlia C Martins, Abna F S Vieira, Olavo Feher","doi":"10.1093/skinhd/vzaf038","DOIUrl":"10.1093/skinhd/vzaf038","url":null,"abstract":"<p><p>Xeroderma pigmentosum (XP) is a rare genetic disorder associated with defective DNA repair, leading to extreme ultraviolet sensitivity and a significantly elevated risk of malignancies. This case report details a patient with XP and metastatic melanoma who achieved complete clinical remission with pembrolizumab, highlighting the potential efficacy of immune checkpoint inhibitors in tumours with high mutational burdens. These findings underscore a promising therapeutic avenue for this vulnerable population with limited treatment options.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 5","pages":"378-381"},"PeriodicalIF":0.0,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12480738/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Skin health and disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1